G. N. Zyuz’kov

1.1k total citations
137 papers, 869 citations indexed

About

G. N. Zyuz’kov is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, G. N. Zyuz’kov has authored 137 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 28 papers in Pharmacology and 27 papers in Oncology. Recurrent topics in G. N. Zyuz’kov's work include Neurogenesis and neuroplasticity mechanisms (20 papers), Plant-based Medicinal Research (18 papers) and Cytokine Signaling Pathways and Interactions (17 papers). G. N. Zyuz’kov is often cited by papers focused on Neurogenesis and neuroplasticity mechanisms (20 papers), Plant-based Medicinal Research (18 papers) and Cytokine Signaling Pathways and Interactions (17 papers). G. N. Zyuz’kov collaborates with scholars based in Russia, United Kingdom and Czechia. G. N. Zyuz’kov's co-authors include В. В. Жданов, А. М. Дыгай, Е. В. Симанина, L. А. Miroshnichenko, Л. А. Ставрова, Е. Д. Гольдберг, Е. В. Удут, Н. И. Суслов, В. В. Удут and М. Г. Данилец and has published in prestigious journals such as SHILAP Revista de lepidopterología, Current Molecular Pharmacology and Journal of Basic and Clinical Physiology and Pharmacology.

In The Last Decade

G. N. Zyuz’kov

129 papers receiving 855 citations

Peers

Countries citing papers authored by G. N. Zyuz’kov

Since Specialization

Citations

This map shows the geographic impact of G. N. Zyuz’kov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. N. Zyuz’kov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. N. Zyuz’kov more than expected).

Fields of papers citing papers by G. N. Zyuz’kov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. N. Zyuz’kov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. N. Zyuz’kov. The network helps show where G. N. Zyuz’kov may publish in the future.

Co-authorship network of co-authors of G. N. Zyuz’kov

This figure shows the co-authorship network connecting the top 25 collaborators of G. N. Zyuz’kov. A scholar is included among the top collaborators of G. N. Zyuz’kov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. N. Zyuz’kov. G. N. Zyuz’kov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting Adenylate Cyclase: A Novel Concept for Stimulation of Neurogenesis and Pharmacotherapy of Alzheimer's Disease 2024 ·Central Nervous System Agents in Medicinal Chemistry ·G. N. Zyuz’kov, (unknown), (unknown), Е. В. Симанина, (unknown)	1
2	Investigation of wound healing activity of the flavonoid schaftoside isolated from Lychnis chalcedonica 2023 ·Research Results in Pharmacology ·(unknown), (unknown), Л. Н. Зибарева, (unknown), Н. И. Суслов, (unknown), G. N. Zyuz’kov, (unknown), (unknown)	3
3	Insight into JNK Inhibition-based Strategy for the Treatment ofAlzheimer's Disease 2023 ·Current Enzyme Inhibition ·G. N. Zyuz’kov, (unknown), (unknown), Е. В. Симанина, (unknown), (unknown)	2
4	Prospects for the Therapeutic Potential of Inhibitors Targeting JNK and p53 in Alzheimer's Disease 2023 ·Advancements in Life Sciences ·G. N. Zyuz’kov, L. А. Miroshnichenko, (unknown), (unknown)	1
5	Prospect of Using ERK1/2 and р38 in Regeneration-Competent Cells of Nervous Tissue as a Drug Targets for Treating Alzheimer’s Disease 2022 ·Biointerface Research in Applied Chemistry ·G. N. Zyuz’kov, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
6	Nf-κb: A Target for Synchronizing the Functioning Nervous TissueProgenitors of Different Types in Alzheimer's Disease 2022 ·Current Molecular Pharmacology ·G. N. Zyuz’kov, L. А. Miroshnichenko, (unknown), (unknown)	10
7	Targeting JNK as a Novel Approach to Drug Metabolism Regulation 2021 ·Biointerface Research in Applied Chemistry ·G. N. Zyuz’kov, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), В. В. Удут, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
8	Inhibition of Adenylate Cyclase of Regeneration-Competent Cells of Nervous Tissue: a Novel Approach for the Treatment of Alcoholic Encephalopathy 2021 ·Biointerface Research in Applied Chemistry ·G. N. Zyuz’kov, (unknown), (unknown), (unknown), Е. В. Симанина, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	7
9	Targeting cAMP-pathway in Regeneration-competent Cells of Nervous Tissue: Potential to Create a Novel Drug for Treatment of Ethanol-inducedNeurodegeneration 2021 ·Central Nervous System Agents in Medicinal Chemistry ·G. N. Zyuz’kov, (unknown), (unknown), Е. В. Симанина, Л. А. Ставрова	17
10	Intracellular signaling molecules of nerve tissue progenitors as pharmacological targets for treatment of ethanol-induced neurodegeneration 2021 ·Journal of Basic and Clinical Physiology and Pharmacology ·G. N. Zyuz’kov, (unknown), Е. В. Симанина, Л. А. Ставрова, (unknown)	13
11	Role of JNK and p53 in Implementation of Functions of Various Types of Regeneration-Competent Cells of the Nervous Tissue 2021 ·Bulletin of Experimental Biology and Medicine ·G. N. Zyuz’kov, В. В. Жданов, L. А. Miroshnichenko, (unknown), Е. В. Симанина, Л. А. Ставрова, М. Г. Данилец, (unknown), (unknown)	5
12	Prospects for the Use of NF-кb Inhibitors to Stimulate the Functions of Regeneration-Competent Cells of Nerve Tissue and Neuroregeneration in Ethanol-Induced Neurodegeneration 2020 ·Biointerface Research in Applied Chemistry ·G. N. Zyuz’kov, (unknown), (unknown), (unknown), Е. В. Симанина, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	15
13	The Foresight for Practical Realization of Research in Regenerative Medicine and Cell Technologies 2019 ·Zenodo (CERN European Organization for Nuclear Research) ·G. N. Zyuz’kov	4
14	Mechanisms of Erythropoietin–Stimulating Action of Anti-Erythropoietin Release-Active Antibodies in Complex Treatment of Experimental Anemia during Gestation 2016 ·Bulletin of Experimental Biology and Medicine ·(unknown), Е. В. Удут, В. В. Жданов, (unknown), L. А. Miroshnichenko, Е. В. Симанина, (unknown), G. N. Zyuz’kov, (unknown), Л. А. Ставрова, (unknown), А. М. Дыгай	0
15	Involvement of JAK1, JAK2, and JAK3 in Stimulation of Functional Activity of Mesenchymal Progenitor Cells by Fibroblast Growth Factor 2016 ·Bulletin of Experimental Biology and Medicine ·G. N. Zyuz’kov, В. В. Жданов, Е. В. Удут, L. А. Miroshnichenko, Е. В. Симанина, (unknown), Л. А. Ставрова, В. В. Удут, (unknown), А. М. Дыгай	8
16	Antitumor Effects of Sorbus aucuparia L. Extract Highly Saturated with Anthocyans and Their Mechanisms 2016 ·Bulletin of Experimental Biology and Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), В. В. Жданов, G. N. Zyuz’kov	14
17	Anti-Inflammatory Activity of Diterpene Alkaloids from Aconitum baikalense 2014 ·Bulletin of Experimental Biology and Medicine ·(unknown), (unknown), Н. И. Суслов, G. N. Zyuz’kov, (unknown), (unknown), (unknown)	37
18	Comparison of Specifi c Activity of Granulocytopoiesis Stimulators after Treatment with Cytostatics with Different Mechanisms of Action 2013 ·Bulletin of Experimental Biology and Medicine ·А. М. Дыгай, В. В. Жданов, L. А. Miroshnichenko, G. N. Zyuz’kov, Е. В. Удут, Е. В. Симанина, Л. А. Ставрова, (unknown), (unknown)	5
19	Blood system regulation mechanisms in oxygen insufficiency and participation of neural stem cells in the adaptation to hypoxia 2006 ·Bulletin of Siberian Medicine ·(unknown), А. М. Дыгай, G. N. Zyuz’kov	1
20	Role of Thy-1,2+ cells in hemopoiesis regulation during hypoxia 2006 ·Bulletin of Experimental Biology and Medicine ·Е. Д. Гольдберг, А. М. Дыгай, G. N. Zyuz’kov	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact